Macroview Investment Management LLC Exelixis, Inc. Transaction History

Macroview Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$20.67 - $26.94 $2,645 - $3,448	-128 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$16.46 - $27.42 $938 - $1,562	-57 Reduced 30.81%	128 $3,000
Q1 2020 May 06, 2020	BUY	$14.46 - $21.8 $2,241 - $3,379	155 Added 516.67%	185 $3,000
Q4 2018 Feb 07, 2019	SELL	$13.65 - $21.8 $2,893 - $4,621	-212 Reduced 87.6%	30 $1,000
Q3 2018 Nov 02, 2018	BUY	$15.87 - $22.4 $841 - $1,187	53 Added 28.04%	242 $4,000
Q2 2018 Jul 31, 2018	BUY	$18.56 - $22.45 $2,951 - $3,569	159 Added 530.0%	189 $4,000
Q1 2018 May 07, 2018	BUY	$22.15 - $31.89 $664 - $956	30 New	30 $1,000

566

251M

1.45M

1.13M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.